Solid Biosciences Inc. (SLDB) financial statements (2021 and earlier)

Company profile

Business Address 141 PORTLAND STREET, FIFTH FLOOR
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments15584122
Cash and cash equivalents1557686
Short-term investments 736
Other undisclosed current assets436
Total current assets:15986129
Noncurrent Assets
Operating lease, right-of-use asset45
Property, plant and equipment81210
Restricted cash and investments000
Other noncurrent assets000
Total noncurrent assets:121711
TOTAL ASSETS:171103140
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities121612
Accounts payable374
Accrued liabilities998
Deferred revenue10 
Debt020
Other liabilities 00
Other undisclosed current liabilities2  
Total current liabilities:241812
Noncurrent Liabilities
Long-term debt and lease obligation351
Finance lease, liability11
Capital lease obligations1
Operating lease, liability24
Liabilities, other than long-term debt12 1
Deferred revenue10 
Other liabilities1 1
Total noncurrent liabilities:1552
Total liabilities:392314
Stockholders' equity
Stockholders' equity attributable to parent13280125
Common stock000
Additional paid in capital537396324
Accumulated other comprehensive income (loss) 0(0)
Accumulated deficit(405)(316)(199)
Total stockholders' equity:13280125
TOTAL LIABILITIES AND EQUITY:171103140

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Operating expenses(88)(119)(76)
Operating loss:(88)(119)(76)
Nonoperating income021
Investment income, nonoperating021
Other nonoperating income010
Net loss available to common stockholders, diluted:(88)(117)(75)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(88)(117)(75)
Other undisclosed comprehensive income (loss)(0)00
Comprehensive loss, net of tax, attributable to parent:(88)(117)(75)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: